240. Phenylketonuria Clinical trials / Disease details


Clinical trials : 138 Drugs : 106 - (DrugBank : 11) / Drug target gene : 1 - Drug target pathways : 5

  
6 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05096988
(ClinicalTrials.gov)
November 23, 202114/10/2021A Study to Evaluate the Acceptability, Tolerance and Adherence of Children and Adults Consuming PKU Sphere Liquid, a Food for Special Medical Purposes (FSMP), for the Dietary Management of Phenylketonuria (PKU)A Study to Evaluate the Acceptability, Tolerance and Adherence of Children and Adults Consuming PKU Sphere Liquid, a Food for Special Medical Purposes (FSMP), for the Dietary Management of Phenylketonuria (PKU)PhenylketonuriasDietary Supplement: PKU sphere liquidVitaflo International, LtdNULLRecruiting3 YearsN/AAll15N/AUnited Kingdom
2NCT04679467
(ClinicalTrials.gov)
January 15, 202026/11/2020Evaluation of PKU Sphere in ItalyAn Acceptability Study to Evaluate the Tolerance, Adherence and Metabolic Control of Patients With Phenylketonuria (PKU) Consuming PKU Sphere™, a Glycomacropeptide (GMP) Based Protein Substitute, When Introduced According to a Practical Guide to PKU Sphere.Phenylketonurias;PKUDietary Supplement: PKU sphereVitaflo International, LtdNULLRecruiting3 YearsN/AAll20N/AItaly
3NCT04224142
(ClinicalTrials.gov)
July 29, 20197/10/2019Evaluation of PKU Sphere in Maternal PKUAn Observational Study to Evaluate Metabolic Control and Dietary Management in Women With PKU Taking PKU Sphere During Pre-conception and/or PregnancyMaternal PhenylketonuriaDietary Supplement: PKU sphereVitaflo International, LtdUniversity College London HospitalsRecruiting16 YearsN/AFemale10United Kingdom
4NCT03939052
(ClinicalTrials.gov)
July 19, 20191/5/2019Protein Requirements in Adults With Phenylketonuria (PKU)Protein Requirements in Phenylketonuria (PKU) Patients Compared Using PKU Sphere™ | Glycomacropeptide (GMP) and an L-amino Acid-based ProductPhenylketonuriaDietary Supplement: Free amino acids intakeUniversity of British ColumbiaVitaflo International, LtdRecruiting19 Years50 YearsAll6N/ACanada
5NCT03771391
(ClinicalTrials.gov)
December 6, 20187/12/2018Multicentre Study Project to Evaluate the New Generation of Protein Supplements With Glycomacropeptide (GMP) in Patients With Phenylketonuria (PKU) Aged 10 Years and Older Over a 16 Week Period.Multicentre Study Project to Evaluate the New Generation of Protein Supplements With Glycomacropeptide (GMP) in Patients With Phenylketonuria (PKU) Aged 10 Years and Older Over a 16 Week Period.PhenylketonuriasDietary Supplement: PKU SphereVitaflo International, LtdKreiskliniken Reutlingen;Johannes Gutenberg University MainzActive, not recruiting10 YearsN/AAll15N/AGermany
6NCT03419819
(ClinicalTrials.gov)
May 1, 20183/1/2018Evaluation of PKU SphereEvaluation of the Acceptability, Tolerance, and Satiety of PKU Sphere, a Glycomacropeptide (GMP) Based Medical Food in Patients With Phenylketonuria (PKU).PhenylketonuriasDietary Supplement: PKU SphereVitaflo International, LtdOregon Health and Science UniversityCompleted3 YearsN/AAll28N/AUnited States